Human Genome Epidemiology Literature Finder
Records 1 - 27 (of 27 Records) |
Query Trace: Thrombocytosis and CALR[original query] |
---|
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. Blood 2014 Mar 123 (10): 1552-5. Rotunno Giada, Mannarelli Carmela, Guglielmelli Paola, Pacilli Annalisa, Pancrazzi Alessandro, Pieri Lisa, Fanelli Tiziana, Bosi Alberto, Vannucchi Alessandro M, |
The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Journal of hematology & oncology 2014 7 48. Wu Zhiyuan, Zhang Xinju, Xu Xiao, Chen Yuming, Hu Tingting, Kang Zhihua, Li Shibao, Wang Hua, Liu Weiwei, Ma Xiaochao, Guan Mi |
JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis. Journal of Korean medical science 2015 Jul 30 (7): 882-8. Kim Bo Hyun, Cho Young-Uk, Bae Mi-Hyun, Jang Seongsoo, Seo Eul-Ju, Chi Hyun-Sook, Choi Yunsuk, Kim Dae-Young, Lee Jung-Hee, Lee Je-Hwan, Lee Kyoo-Hyung, Park Young-Mi, Lee Jong-Keuk, Park Chan-Jeou |
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort. British journal of haematology 2015 May 169 (4): 584-9. Randi Maria L, Geranio Giulia, Bertozzi Irene, Micalizzi Concetta, Ramenghi Ugo, Tucci Fabio, Notarangelo Lucia D, Ladogana Saverio, Menna Giuseppe, Giordano Paola, Consarino Caterina, Farruggia Piero, Zanazzo Giulio A, Fiori Giovanni M, Burnelli Roberta, Russo Giovanna, Jankovich Momcilo, Peroni Edoardo, Duner Elena, Basso Giuseppe, Fabris Fabrizio, Putti Maria |
Thrombotic risk correlates with mutational status in true essential thrombocythemia. European journal of clinical investigation 2016 Jun . Bertozzi I, Peroni E, Coltro G, Bogoni G, Cosi E, Santarossa C, Fabris F, Randi M |
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 2016 12 129 (6): 680-692. Rumi Elisa, Cazzola Mar |
Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia. The Journal of molecular diagnostics : JMD 2016 Nov . Usseglio Fabrice, Beaufils Nathalie, Calleja Anne, Raynaud Sophie, Gabert Je |
[Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease]. Terapevticheskii arkhiv 2017 89 (7): 4-9. Melikyan A L, Subortseva I N, Sudarikov A B, Kovrigina A M, Gilyazitdinova E A, Kolosheinova T I, Abdullaev A O, Treglazova S |
[Mutation of CALR Gene in Patients with Chronic Myeloproliferative Neoplasm and Its Clinical Significance]. Zhongguo shi yan xue ye xue za zhi 2017 Feb 25 (1): 151-156. Tang Qin, Zhang Xiu-Wen, Xia Lei, Jiang Nai- |
The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia. American journal of hematology 2017 Feb . Mudireddy Mythri, Barraco Daniela, Hanson Curtis A, Pardanani Animesh, Gangat Naseema, Tefferi Ayal |
[Detection and Diagnostic Values of JAK2, CALR, MPL Gene Mutations in 208 Cases of BCR/ABL1 Negative Chronic Myeloproliferative Diseases]. Zhongguo shi yan xue ye xue za zhi 2018 Aug 26 (4): 1122-1128. Li Zhen-Ling, Gao Li, Zhang Hui, Zhang Chun-Xia, Chen Yan-Rong, Huang Fan-Zhou, Gong Ming, Gao Ya-Yue, Tang Yin, Ma Yi-G |
Skewed ratio between type 1 and type 2 calreticulin mutations in essential thrombocytosis patients with concomitant Janus kinase 2 V617F mutation. Experimental hematology 2018 10 68 62-65. Haunstrup Laura M, Ebbesen Lene H, Hansen Maria, Severinsen Marianne T, Aggerholm An |
[The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms]. Zhonghua nei ke za zhi 2019 12 59 (1): 35-39. Lyu X D, Li Y W, Guo Z, Xin Y P, Hu J Y, Fan R H, Song Y |
CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms. Scientific reports 2019 12 9 (1): 19838. Belcic Mikic Tanja, Pajic Tadej, Sever Matj |
[Gene mutation spectrum and clinical characteristics analysis of 178 patients with essential thrombocytosis]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2019 11 40 (10): 837-842. Dong H, Fu R F, Ju M K, Sun T, Liu X F, Xue F, Chi Y, Yang R C, Zhang |
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression. British journal of haematology 2019 Nov . Cottin Laurane, Riou Jérémie, Orvain Corentin, Ianotto Jean Christophe, Boyer Françoise, Renard Maxime, Truchan-Graczyk Matgorzata, Murati Anne, Jouanneau-Courville Rébecca, Allangba Olivier, Mansier Olivier, Burroni Barbara, Rousselet Marie-Christine, Quintin-Roué Isabelle, Martin Antoine, Sadot-Lebouvier Sophie, Delneste Yves, Chrétien Jean-Marie, Hunault-Berger Mathilde, Blanchet Odile, Lippert Eric, Ugo Valérie, Luque Paz Dami |
Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. Journal of clinical pathology 2020 3 73 (11): 728-736. Liu Yen-Chun, Illar Gwendolyn M, Bailey Nathanael Gl |
Mutation Profile in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Single-Center Experience From India. Hematology/oncology and stem cell therapy 2021 3 15 (2): 13-20. Maddali Madhavi, Kulkarni Uday Prakash, Ravindra Niveditha, Arunachalam Arun Kumar, Venkatraman Arvind, Lionel Sharon, Manipadam Marie Therese, Devasia Anup J, Korula Anu, Fouzia N A, Abraham Aby, Srivastava Alok, George Biju, Balasubramanian Poonkuzhali, Mathews Vikr |
Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and Challenges. Clinical lymphoma, myeloma & leukemia 2021 3 21 (6): e569-e578. Singh Suvir, Kaur Komalpreet, Paul Davinder, Jain Kunal, Singh Jagdeep, Narang Vikram, Garg Bhavna, Sood Neena, Dhillon Barjinderj |
Novel modes of MPL activation in triple-negative myeloproliferative neoplasms. Pathology 2022 8 55 (1): 77-85. Samaraweera Saumya E, Geukens Tatjana, Casolari Debora A, Nguyen Tran, Sun Caitlyn, Bailey Sheree, Moore Sarah, Feng Jinghua, Schreiber Andreas W, Parker Wendy T, Brown Anna L, Butcher Carolyn, Bardy Peter G, Osborn Michael, Scott Hamish S, Talaulikar Dipti, Grove Carolyn S, Hahn Christopher N, D'Andrea Richard J, Ross David |
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype. Acta haematologica 2022 11 146 (1): 14-25. Barosi Giovanni, Campanelli Rita, Massa Margherita, Catarsi Paolo, Carolei Adriana, Abbà Carlotta, Villani Laura, Magrini Umberto, Gregato Giuliana, Bertolini Francesco, de Silvestri Annalisa, Gale Robert Peter, Rosti Vittor |
Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan. American journal of clinical pathology 2023 3 . Kuo Ming-Chung, Chuang Wen-Yu, Chang Hung, Lin Tung-Huei, Wu Jin-Hou, Lin Tung-Liang, Ou Che-Wei, Hung Yu-Shin, Huang Ting-Yu, Huang Ying-Jung, Wang Po-Nan, Shih Lee-Yu |
Characterization of myeloproliferative neoplasms in the paediatric and young adult population. British journal of haematology 2023 1 . Harris Zoey, Kaizer Hannah, Wei Aria, Karantanos Theodoros, Williams Donna M, Chaturvedi Shruti, Jain Tania, Resar Linda, Moliterno Alison R, Braunstein Evan |
Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practice. British journal of haematology 2024 7 . Anna L Godfrey, Nikolaos Sousos, Rebecca Frewin, Mahesh Prahladan, Anna C Green, Andrew McGregor, Alesia Khan, Kate Milne, Faisal Amin, Elena Torre, Emma J Gudgin, Jonathan Lambert, Andrew J Wilson, Daniel Royston, Claire N Harrison, Adam J Me |
Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India. Indian journal of pathology & microbiology 2024 5 . Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsy |
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 2024 1 14 (1): 11. Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Teffe |
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 2024 1 14 (1): 10. Giuseppe G Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro M Vannucchi, Paola Guglielmel |
- Page last reviewed:Feb 1, 2024
- Content source: